↓ Skip to main content

Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study

Overview of attention for article published in BMC Neurology, January 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
1 tweeter
facebook
2 Facebook pages
wikipedia
1 Wikipedia page

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
52 Mendeley
citeulike
3 CiteULike
Title
Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study
Published in
BMC Neurology, January 2010
DOI 10.1186/1471-2377-10-10
Pubmed ID
Authors

Richard G Boles, Mary R Lovett-Barr, Amy Preston, B UK Li, Kathleen Adams

Abstract

Cyclic vomiting syndrome (CVS), which is defined by recurrent stereotypical episodes of nausea and vomiting, is a relatively-common disabling condition that is associated with migraine headache and mitochondrial dysfunction. Co-enzyme Q10 (Co-Q) is a nutritional supplement that has demonstrated efficacy in pediatric and adult migraine. It is increasingly used in CVS despite the complete lack of studies to demonstrate its value in treatment

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 6%
Sri Lanka 1 2%
Italy 1 2%
Canada 1 2%
Unknown 46 88%

Demographic breakdown

Readers by professional status Count As %
Other 8 15%
Student > Master 8 15%
Researcher 6 12%
Student > Postgraduate 6 12%
Student > Ph. D. Student 5 10%
Other 19 37%
Readers by discipline Count As %
Medicine and Dentistry 26 50%
Psychology 7 13%
Unspecified 6 12%
Agricultural and Biological Sciences 3 6%
Neuroscience 3 6%
Other 7 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 December 2018.
All research outputs
#3,240,188
of 13,092,437 outputs
Outputs from BMC Neurology
#371
of 1,480 outputs
Outputs of similar age
#42,863
of 182,361 outputs
Outputs of similar age from BMC Neurology
#41
of 199 outputs
Altmetric has tracked 13,092,437 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,480 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 182,361 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 199 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.